Vaccines for Human Medicine
Código 300220 (Harmonized System 2012 by 6 digits)
2022: US$257M, Total Trade Exchange
2022: US$8.67M, International Sales
2022: US$248M, International Purchases
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Vaccines for Human Medicine and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Vaccines for Human Medicine. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 0.091%, Mexican share in global exports - 2022
- 0.48%, Mexican share in global imports - 2022
The visualizations show the global market for Vaccines for Human Medicine. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Vaccines for Human Medicine were N/A. In the same year, the main importing countries for Vaccines for Human Medicine were Belgium (US$12.3B), Germany (US$10.8B), and United States (US$9.29B).